SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,532,003 | -9.2% | 200,653 | -1.0% | 0.06% | +5.2% |
| Q2 2023 | $6,091,749 | -44.9% | 202,653 | -33.6% | 0.06% | -49.1% |
| Q1 2023 | $11,053,012 | -52.7% | 305,079 | -53.5% | 0.11% | -55.3% |
| Q4 2022 | $23,389,960 | -1.7% | 655,732 | -6.7% | 0.26% | -8.6% |
| Q3 2022 | $23,790,000 | +33.5% | 702,808 | +14.0% | 0.28% | +36.1% |
| Q2 2022 | $17,826,000 | -15.3% | 616,375 | -5.4% | 0.20% | +7.3% |
| Q1 2022 | $21,052,000 | +16.9% | 651,355 | +5.4% | 0.19% | +34.5% |
| Q4 2021 | $18,012,000 | +16.6% | 617,701 | +6.7% | 0.14% | +17.4% |
| Q3 2021 | $15,444,000 | -38.6% | 579,073 | -29.1% | 0.12% | -34.2% |
| Q2 2021 | $25,147,000 | +24.8% | 816,731 | +6.1% | 0.18% | +21.1% |
| Q1 2021 | $20,146,000 | – | 769,523 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |